Solopharm pharmaceutical cluster. The development of hormones segment

On June 20, 2023, the groundbreaking ceremony of the pharmaceutical plant for hormonal drugs production (Hormones Plant) took place in the Solopharm industrial zone in St. Petersburg.

The volume of project investments will amount up to 9.5 bln rubles. The planned launch date is the 1st quarter of 2026.

Once again, the German architects from the «d/g consults GmbH» company became the main constructors of the plant. Hormones Plant is already the 2nd project, which is based on the innovative matrix engineering design system. This time the plant will have not only modular walls for clean rooms transformation, but also modular facades. The glass facades of the plant will simultaneously be the walls of clean rooms from the inside, and the outer walls of the building from the outside.

The production of clean rooms panels will be carried out at the Matrix Wall facilities, which was launched in April 2023.

Hormones Plant in numbers:

- The total plant area is 13,260 m2

- The clean room floor area is 5,191 m2

- Number of working places – 250

- Number of production lines – 5

- Production lines capacity is 1,19 bln units/year

40 hormonal drugs are planned to be developed and produced in such areas as pulmonology (bronchial asthma), skin diseases (dermatitis, psoriasis, eczema), otolaryngology (sinusitis, rhinitis, otitis media) and ophthalmology (conjunctivitis, keratitis and other inflammatory eye diseases).